IHA Daily Briefing: Nov. 7

Monday, Nov. 7, 2022
11/10 IHA Webinar on CMS CoPs Covers Patient Rights
IHA Gold Sponsor Helps Hospital Achieve Savings
Medicaid Long-Acting Injectable Medication Payments
CDC Warns of Increased Respiratory Virus Activity
FDA Reports Amoxicillin Shortage
Illinois COVID-19 Data
Briefly Noted

11/10 IHA Webinar on CMS CoPs Covers Patient Rights
Learn about the most problematic standards related to patient rights from the Centers for Medicare & Medicaid Services (CMS): Register for the second of five “CMS Conditions of Participation 2022” webinars held this Thursday, Nov. 10, from noon to 2 p.m.

The webinar series will cover every section of the CMS Hospital Conditions of Participation (CoP) manual and include discussion of recent updates and interpretative guidelines. Designed for hospital and health system leaders, this week’s webinar will especially benefit those in:

  • Compliance;

  • Quality improvement;

  • Risk management;

  • Nursing;

  • Medical staff;

  • Legal affairs; and

  • Emergency department.

Lena Browning, MHA, BSN, RNC-NIC, CSHA, of Nash Healthcare Consulting, will present each webinar, offering tips for a gap analysis to ensure hospital compliance. Browning is a nurse leader, accreditation specialist, and an expert in CMS, The Joint Commission and state regulations.

Thursday’s webinar will zero in on:

  • Restraint guidelines hospitals must follow;

  • The requirement of hospitals to have a grievance policy and procedure;

  • The provision of interpreters for patients with limited English proficiency; and

  • The ability of physician assistants to order restraints.

The registration fee is per webinar and includes an unlimited number of connections within the same hospital or health system corporate office. Subsequent webinars are Nov. 17, Nov. 30 and Dec. 14. Register today.

Contact us with questions.

IHA Gold Sponsor Helps Hospital Achieve Savings
North American Partners in Anesthesia (NAPA), a gold-level IHA Corporate Sponsor, recently worked with a large teaching hospital in North Carolina to create a Perioperative Surgical Home program that achieved savings of $4.1 million in the first year.

After the hospital expanded the program to include 16 service lines, annual return on investment grew to $12 million annually. The new program includes new protocols from pre-op through post-discharge; implementation of a readmission risk assessment tool; standardized order sets; greater surgeon and anesthesiologist engagement; and creation of a post-surgical transitional care clinic.

Learn more from NAPA’s white paper by clicking here.

Medicaid Long-Acting Injectable Medication Payments
On Thursday, IHA submitted comments to the Illinois Dept. of Healthcare and Family Services regarding the Proposed Rule amending 89 Ill. Adm. Code 148, published in the Illinois Register on Sept. 30. IHA’s comments provide recommendations that support behavioral health clinicians being reimbursed for working at the top of their license in hospital settings across Illinois.

The Proposed Rule formalized guidance authorizing payment for long-acting injectable medications administered for mental health or substance use disorder in the hospital inpatient setting. This guidance was originally established by Public Act 102-0043 and adopted as 305 ILCS 5/5-5.4k.

IHA requested broadening eligibility requirements to permit psychiatric nurse practitioners and board-eligible psychiatrists to be prescribers eligible for reimbursement, noting that prescriber qualifications for this reimbursement were not limited to psychiatrists in Public Act 102-0043. To further align with the law, IHA recommended removing a restriction in the Proposed Rule that would limit reimbursement to inpatient psychiatric settings. IHA instead recommended permitting reimbursement for medication administration in any inpatient setting where the patient is most appropriately located for individualized treatment.

Members are encouraged to send comments on the Proposed Rule by Nov. 14 to:

Steffanie Garrett
General Counsel
Illinois Dept. of Healthcare and Family Services
201 South Grand Avenue East, 3rd Floor
Springfield, IL 62763-0002

Contact us with questions.

CDC Warns of Increased Respiratory Virus Activity
On Friday, the Centers for Disease Control and Prevention (CDC) issued a Health Alert Network Health Advisory highlighting increased respiratory virus activity early in the fall and winter season is “placing strain on healthcare systems.” The CDC underscored the co-circulation of respiratory disease, such as respiratory syncytial virus (RSV), influenza viruses, SARS-CoV-2, is especially prevalent among children.

According to CDC surveillance, the levels of respiratory virus activity are “higher than usual for this time of year,” showing an “increase in RSV detections and RSV-associated emergency department visits and hospitalizations in all but two U.S. Department of Health and Human Services (HHS) regions,” including Illinois. The CDC noted that some regions are “already near the seasonal peak levels typically observed in December or January.”

Click here to access specific considerations for healthcare providers included in the CDC’s recent communication. Guidance includes vaccine recommendations; diagnostic testing to inform treatment and clinical management; treatment of patients with suspected or confirmed influenza or COVID-19; and additional resources to assist with patient education efforts.

FDA Reports Amoxicillin Shortage
The U.S. Food and Drug Administration (FDA) recently added the popular antibiotic amoxicillin to its FDA Drug Shortages list. Specifically, the amoxicillin oral powder for suspension is in shortage, according to the FDA. This drug is typically used to treat bacterial infections in children, such as pneumonia and bronchitis.

In addition to this form of the drug, the American Society of Health-System Pharmacists (ASHP) also added additional formulations of amoxicillin to its shortage list, including capsule, tablet and liquid forms. Michael Ganio, senior director of pharmacy practice and quality with ASHP, told Crain’s Chicago Business, “Increased demand for the antibiotic is causing the shortage, not supply chain issues related to the manufacturing, transportation and availability of raw materials.”

The shortage comes as children’s hospitals across the country are navigating a surge in cases of respiratory syncytial virus (RSV), though amoxicillin is not used to treat viral infections like RSV, the flu or COVID-19. Notably, there are alternative antibiotics still available that can be effectively substituted for amoxicillin.  

Illinois COVID-19 Data
To access updated Illinois COVID-19 data on daily case numbers, testing outcomes and deaths, click here. Hospitalization data, including the number of patients in the ICU and patients on ventilators, can be accessed by clicking here. The most recent COVID-19 vaccination data can be found by clicking here. The Illinois Dept. of Public Health (IDPH) updates its COVID-19 data at 1 p.m. Monday – Friday.

Briefly Noted
More than 49,000 U.S. deaths in 2020 were attributed to alcohol, according to Centers for Disease Control and Prevention data published on Friday. While alcohol deaths have been climbing over the last several decades, they increased by 26% between 2019 and 2020. This amounts to nearly the same jump in one year as was reported over the prior decade. In 2020, alcohol caused 13 deaths for every 100,000 people, up from 10.4 deaths for every 100,000 people in 2019.